Incorrect username and/or password, please try again or click to reset.

Sign up for your ticket to see PharmData at the Pharmacy Show for a chance to win a £100 Amazon voucher!

Class 2 Medicines Recall: Pfizer Limited, Oxbryta 500mg Tablets (voxelotor), EL(24)A/44

2024-09-30 12:15:15 (4 day(s) ago)

Summary

Pfizer Limited is recalling all distributed batches of Oxbryta 500 mg Tablets. Pfizer Limited has informed the MHRA that the product is being withdrawn due to emerging data from clinical trials and registry-based studies.

Read full MHRA article

Respond to this alert